Barclays’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.3M | Buy |
438,409
+212,287
| +94% | +$6.9M | ﹤0.01% | 958 |
|
|
2025
Q1 | $8.54M | Sell |
226,122
-28,763
| -11% | -$1.09M | ﹤0.01% | 1109 |
|
|
2024
Q4 | $20.9M | Buy |
254,885
+45,132
| +22% | +$3.69M | 0.01% | 762 |
|
|
2024
Q3 | $24M | Buy |
209,753
+81,801
| +64% | +$9.35M | 0.01% | 692 |
|
|
2024
Q2 | $9.66M | Sell |
127,952
-1,300
| -1% | -$98.2K | ﹤0.01% | 922 |
|
|
2024
Q1 | $8.83M | Sell |
129,252
-72,446
| -36% | -$4.95M | ﹤0.01% | 1094 |
|
|
2023
Q4 | $12.7M | Buy |
201,698
+31,286
| +18% | +$1.96M | ﹤0.01% | 924 |
|
|
2023
Q3 | $8.69M | Buy |
170,412
+68,904
| +68% | +$3.51M | 0.01% | 912 |
|
|
2023
Q2 | $5.07M | Buy |
101,508
+9,303
| +10% | +$465K | ﹤0.01% | 1214 |
|
|
2023
Q1 | $3.46M | Sell |
92,205
-21,647
| -19% | -$811K | ﹤0.01% | 1292 |
|
|
2022
Q4 | $5.46M | Buy |
113,852
+53,853
| +90% | +$2.58M | ﹤0.01% | 1061 |
|
|
2022
Q3 | $1.44M | Buy |
59,999
+57,353
| +2,168% | +$1.38M | ﹤0.01% | 1867 |
|
|
2022
Q2 | $58K | Sell |
2,646
-47,154
| -95% | -$1.03M | ﹤0.01% | 3674 |
|
|
2022
Q1 | $1.2M | Buy |
+49,800
| New | +$1.2M | ﹤0.01% | 2170 |
|